157 related articles for article (PubMed ID: 36121439)
1. A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD.
Kloosterman R; Zago-Schmitt M; Grabell J; Thibeault L; De Lima PA; Bowman M; Tyryshkin K; Hindmarch CCT; Renwick N; James P
Blood Adv; 2023 Apr; 7(8):1477-1487. PubMed ID: 36121439
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.
Bowman M; Casey L; Selvam SN; Lima PDA; Rawley O; Hinds M; Tuttle A; Grabell J; Iorio A; Walker I; Lillicrap D; James P
J Thromb Haemost; 2022 Jul; 20(7):1599-1609. PubMed ID: 35466528
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.
Starke RD; Paschalaki KE; Dyer CE; Harrison-Lavoie KJ; Cutler JA; McKinnon TA; Millar CM; Cutler DF; Laffan MA; Randi AM
Blood; 2013 Apr; 121(14):2773-84. PubMed ID: 23355534
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted pathomolecular mechanism of a VWF large deletion involved in the pathogenesis of severe VWD.
Yadegari H; Jamil MA; Müller J; Marquardt N; Rawley O; Budde U; El-Maarri O; Lillicrap D; Oldenburg J
Blood Adv; 2022 Feb; 6(3):1038-1053. PubMed ID: 34861678
[TBL] [Abstract][Full Text] [Related]
5. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
Meinkoth JH; Meyers KM
Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
[TBL] [Abstract][Full Text] [Related]
6. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
[TBL] [Abstract][Full Text] [Related]
7. Variability of von Willebrand factor-related parameters in endothelial colony forming cells.
de Jong A; Weijers E; Dirven R; de Boer S; Streur J; Eikenboom J
J Thromb Haemost; 2019 Sep; 17(9):1544-1554. PubMed ID: 31265169
[TBL] [Abstract][Full Text] [Related]
8. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.
van Loon JE; Sanders YV; de Wee EM; Kruip MJ; de Maat MP; Leebeek FW
PLoS One; 2012; 7(7):e40624. PubMed ID: 22792389
[TBL] [Abstract][Full Text] [Related]
9. A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies.
Yadegari H; Jamil MA; Marquardt N; Oldenburg J
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328514
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA.
de Jong A; Dirven RJ; Boender J; Atiq F; Anvar SY; Leebeek FWG; van Vlijmen BJM; Eikenboom J
Thromb Haemost; 2020 Nov; 120(11):1569-1579. PubMed ID: 32803740
[TBL] [Abstract][Full Text] [Related]
11. Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells.
Cox AA; Liu A; Ng CJ
PLoS One; 2024; 19(2):e0298133. PubMed ID: 38363768
[TBL] [Abstract][Full Text] [Related]
12. Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.
Hawke L; Bowman ML; Poon MC; Scully MF; Rivard GE; James PD
Blood; 2016 Jul; 128(4):584-93. PubMed ID: 27317792
[TBL] [Abstract][Full Text] [Related]
13. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
[TBL] [Abstract][Full Text] [Related]
14. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
[TBL] [Abstract][Full Text] [Related]
15. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
16. Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease.
Ewenstein BM; Inbal A; Pober JS; Handin RI
Blood; 1990 Apr; 75(7):1466-72. PubMed ID: 2317558
[TBL] [Abstract][Full Text] [Related]
17. Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Nakajima Y; Nogami K; Yada K; Ogiwara K; Furukawa S; Shimonishi N; Shima M
Haemophilia; 2019 May; 25(3):e174-e179. PubMed ID: 30866149
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of slightly reduced von Willebrand factor activity.
Bykowska K; Ceglarek B
Pol Arch Intern Med; 2020 Mar; 130(3):225-231. PubMed ID: 31990275
[TBL] [Abstract][Full Text] [Related]
19. The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease.
Seaman CD; Ragni MV
Clin Appl Thromb Hemost; 2018 Apr; 24(3):434-438. PubMed ID: 28874064
[TBL] [Abstract][Full Text] [Related]
20. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.
Wieczorek I; Ludlam CA; MacGregor IR
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
